Connect with us

Life Sciences

Hapbee Technologies partners with Reputable Health to develop AI-based sleep routines

Reputable Health platform uses AI technology to optimize health by providing recommendations based on real-world data
The post Hapbee Technologies partners…

Published

on

This article was originally published by Mugglehead

Hapbee Technologies (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) and AI-based health technology company, Reputable Health are joining forces using artificial intelligence (AI) to help insomnia sufferers find relief.

Announced on Wednesday, the collaboration is to create personalized sleep routines that will be accessible through Hapbee products. These routines will be developed using AI-powered algorithms that analyze consumers’ sleep data gathered through the Reputable Health platform.

Hapbee has developed a patented biostreaming technology that utilizes ultra-low electromagnetic frequencies (ulRFE) derived from compounds such as caffeine, nicotine, and melatonin. These biostreams are delivered digitally through Hapbee-powered devices like the Smart Sleep Pad and Neckband, enabling people to optimize their sleep, performance, and moods without experiencing the negative side effects or dependencies associated with ingesting these substances.

Reputable Health is a platform that utilizes AI technology to optimize health by providing recommendations based on real-world data. Hapbee has partnered with Reputable Health to offer a personalized digital wellness solution to its users. This collaboration will begin with a focus on improving sleep health, providing a comprehensive approach to help individuals achieve better sleep.

“Partnering with Reputable Health will enable us to continue to innovate our next-gen wellness solution with a personalized experience, optimized based on the users’ own real-world data, allowing them to impact their wellness in a way that is uniquely tailored to their individual needs,” said Yona Shtern, CEO of Hapbee.

Image via Hapbee Technologies.

Read more: Vivos Therapeutics new device could provide substantial relief for migraine sufferers

Read more: Filament Health and Jaguar Health form botanical pharmaceutical joint venture

Reputable Health’s makes health recommendations based on gathered data

Reputable Health’s platform will gathers anonymized health data from various sources, including wearables, lab tests, genomics, and health experiments. This data will be used to provide personalized recommendations to Hapbee users based on their individual health goals.

Hapbee and Reputable Health are collaborating to assist users in achieving their sleep goals by utilizing Hapbee’s ulRFE technology and advanced health analytics.

This includes improving the ability to fall asleep quickly, maintaining uninterrupted sleep throughout the night, and waking up feeling refreshed in the morning.

“By combining our AI-powered platform with Hapbee’s unique digital wellness technology, we will be able to provide users with personalized recommendations that are based on real-world data, enabling them to achieve their health and wellness goals more effectively,” said Dr. Kyle Bergquist, head of operations and business development for Reputable Health.

.

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Joseph Morton on Twitter

joseph@mugglehead.com

The post Hapbee Technologies partners with Reputable Health to develop AI-based sleep routines appeared first on Mugglehead Magazine.

genomics
therapeutics
wellness

pharmaceutical
device
devices
artificial intelligence

health analytics
digital wellness

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending